PATENT CLAIM ANALYSIS

Application Number: 16113635
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-12
Patent Classification: ["514", "063000"]

Abstract:
The present invention provides a compound having a cholinergic muscarinic M1 receptor positive allosteric modulator activity, which may be useful as a prophylactic or therapeutic drug for Alzheimer's disease, schizophrenia, pain, sleep disorder, Parkinson's disease dementia, dementia with Lewy bodies and the like. The present invention relates to a compound represented by the formula (I) or a salt thereof: wherein each symbol is as defined in the attached DESCRIPTION.

Claim (Index 16):
A medicament comprising the compound according to  claim 1  or a salt thereof.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 96.0
- Lexical Diversity: 1.34426
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15735418', '15769295', '15830634', '16083295', '15306012']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8278095400743148
- 35 USC 102 Novelty (BERT): 0.5735201175140932
- Combined Prediction Score: 0.8023805978182927
- Mean Citation Score: 465.1022
- Max Citation Score: 486.07037
- Similarity Product: 398.0314318878019

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test